SMS Pharmaceuticals Ltd

BSE: SMSPHARMA532815ISIN INE812G01025

Healthcare
Pharmaceuticals
BSE Healthcare

Share price

₹526.40+12.70 (+2.47%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹535.35
52W low: ₹270.80
Off 52W high: -1.67%
1M return: +10.31%
3M return: +44.36%
6M return: +27.09%
1Y return: +87.06%
20D avg volume: 27,792
50 DMA: ₹435.46
200 DMA: ₹391.83

Key ratios Consolidated

Market cap: ₹4,930 Cr
Current price: ₹526.40
52W high / low: ₹535.35 / ₹270.80
Face value: ₹1.00
P/E: 42.15
P/B: 5.85
EPS (TTM): ₹12.49
Book value / share: ₹89.98
ROE: —
ROCE: 13.80%
Operating margin: —
Net margin: —
Debt / equity: 0.46
Net debt: ₹319.17 Cr
Interest cover: 6.05
Dividend yield: 0.08%
Dividend / share (TTM): ₹0.40
Payout: 3.20%
Cash conversion cycle: 183.7 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	316.09	206.97	237.95	210.45	242.43	196.05	248.20	173.35	196.75	164.45	245.80	161.48
	1.34	1.74	2.57	3.75	1.43	0.59	1.42	2.13	1.30	1.37	1.65	1.49
	317.43	208.71	240.52	214.20	243.86	196.64	249.62	175.48	198.05	165.82	247.44	162.97
	264.61	181.50	213.46	183.04	209.82	172.27	221.09	153.04	178.51	143.99	225.71	146.45
	168.08	136.65	128.46	139.19	106.56	146.66	117.54	118.32	158.77	107.24	97.47	132.48
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	27.26	23.54	29.47	21.05	19.25	18.18	26.63	18.64	17.93	16.88	20.12	14.02
	5.74	5.50	5.28	6.22	5.74	5.84	5.07	4.20	4.61	4.67	5.61	5.95
	10.44	9.99	10.13	10.02	10.02	9.75	8.64	8.70	8.62	8.38	7.92	8.01
	40.73	29.96	35.36	31.98	34.99	27.52	32.85	15.26	9.67	7.90	9.51	7.69
	52.82	27.20	27.07	31.16	34.04	24.37	28.52	22.44	19.54	21.83	21.74	16.53
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	52.82	27.20	27.07	31.16	34.04	24.37	28.52	22.44	19.54	21.83	21.74	16.53
	13.25	7.00	6.10	7.97	8.91	5.65	8.44	5.36	5.68	5.46	5.68	4.24
	39.85	20.91	32.71	23.47	25.31	20.49	20.32	18.24	14.10	16.48	17.28	11.48
	4.26	2.23	3.58	2.59	2.84	2.31	2.40	2.15	1.67	1.95	2.04	1.36
Key metrics
	69.00	42.69	42.48	47.40	49.80	39.96	42.23	35.34	32.77	34.88	35.27	30.49
	21.80%	20.60%	17.90%	22.50%	20.50%	20.40%	17.00%	20.40%	16.70%	21.20%	14.30%	18.90%
	12.60%	10.10%	13.70%	11.20%	10.40%	10.50%	8.20%	10.50%	7.20%	10.00%	7.00%	7.10%
	5.60%	—	3.20%	—	4.40%	—	4.10%	—	—	—	—	—
	30.40%	5.60%	-4.10%	21.40%	23.20%	19.20%	1.00%	7.40%	—	—	—	—
	57.40%	2.00%	61.00%	28.70%	79.50%	24.30%	17.60%	58.90%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	971.46	886.87	782.75	709.26	522.05	519.87
	9.40	8.35	6.22	4.46	4.89	5.20
	980.86	895.23	788.97	713.72	526.94	525.07
	842.61	778.59	696.63	647.62	521.59	456.57
	572.38	516.44	501.87	425.26	299.73	387.95
	0.00	0.00	0.00	—	—	—
	101.32	87.96	80.08	64.15	55.04	51.02
	22.74	23.08	18.54	23.46	21.91	18.88
	40.58	39.92	34.34	31.52	32.12	32.15
	138.03	134.29	126.61	30.79	19.37	—
	138.25	116.64	92.34	66.11	5.35	68.50
	0.00	0.00	0.00	0.00	0.00	0.00
	138.25	116.64	92.34	66.11	5.35	68.50
	34.32	28.64	24.94	16.91	1.47	0.62
	116.94	101.99	69.14	49.83	-7.06	62.22
	12.66	11.15	8.16	5.89	-0.83	7.35
Key metrics
	201.57	179.64	145.22	121.09	59.38	119.53
	20.75%	20.30%	18.60%	17.10%	11.40%	23.00%
	12.04%	11.50%	8.80%	7.00%	-1.40%	12.00%
	—	13.80%	13.40%	—	—	—
	12.96%	13.30%	10.40%	35.90%	0.40%	—
	38.62%	47.50%	38.80%	805.80%	-111.30%	—
	—	-71.34	-41.67	—	—	—
	—	0.58	1.18	—	—	—
	—	0.46	0.49	—	—	—
	—	319.17	269.35	—	—	—
	—	183.7	174.5	—	—	—
Balance sheet
	—	1,362	1,153	—	—	—
	—	638.01	554.47	—	—	—
	—	45.88	41.40	—	—	—
	—	215.87	203.23	—	—	—
	—	351.21	284.73	—	—	—
	—	21.42	14.64	—	—	—
	—	531.22	530.85	—	—	—
	—	120.43	113.92	—	—	—
	—	352.98	324.37	—	—	—
	—	365.05	310.75	—	—	—
	—	193.41	171.39	—	—	—
	—	171.64	139.36	—	—	—
	—	785.81	639.64	—	—	—
Cash flow
	—	59.22	81.71	—	—	—
	—	-130.78	-123.43	—	—	—
	—	76.03	47.08	—	—	—
	—	130.56	123.38	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	316.07	206.97	237.95	210.45	242.43	196.05	248.20	173.35	196.75	164.45	245.80	161.48
	1.34	1.74	2.57	3.75	1.43	0.59	1.42	2.13	1.30	1.37	1.65	1.49
	317.41	208.71	240.52	214.20	243.86	196.64	249.62	175.48	198.05	165.82	247.44	162.97
	264.89	180.57	213.48	182.89	209.81	172.78	220.56	152.95	178.11	144.03	225.84	146.56
	169.24	135.72	128.31	139.13	106.58	147.29	117.01	118.22	158.38	107.29	97.60	132.60
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	24.80	23.30	29.43	21.05	19.25	18.18	26.63	18.64	17.93	16.88	20.12	14.02
	26.92	5.50	5.28	6.22	5.74	5.84	5.07	4.20	4.61	4.67	5.61	5.95
	5.74	9.99	10.13	10.02	10.02	9.75	8.64	8.70	8.62	8.38	7.92	8.01
	26.22	29.90	35.31	31.90	34.95	27.40	32.84	15.26	9.67	7.90	9.51	7.69
	52.53	28.14	27.05	31.31	34.06	23.86	29.06	22.53	19.94	21.78	21.61	16.41
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	52.53	28.14	27.05	31.31	34.06	23.86	29.06	22.53	19.94	21.78	21.61	16.41
	13.39	7.01	6.12	7.97	8.91	5.65	8.44	5.36	5.68	5.46	5.68	4.24
	39.13	21.13	20.92	23.34	25.14	18.21	20.62	17.17	14.26	16.33	15.92	12.17
	4.18	2.26	2.29	2.57	2.82	2.05	2.43	2.03	1.68	1.93	1.88	1.44
Key metrics
	85.19	43.63	42.46	47.55	49.82	39.45	42.77	35.43	33.17	34.83	35.14	30.37
	27.00%	21.10%	17.80%	22.60%	20.60%	20.10%	17.20%	20.40%	16.90%	21.20%	14.30%	18.80%
	12.40%	10.20%	8.80%	11.10%	10.40%	9.30%	8.30%	9.90%	7.20%	9.90%	6.50%	7.50%
	7.40%	—	3.10%	—	4.30%	—	4.00%	—	—	—	—	—
	30.40%	5.60%	-4.10%	21.40%	23.20%	19.20%	1.00%	7.40%	—	—	—	—
	55.60%	16.00%	1.50%	35.90%	76.30%	11.50%	29.50%	41.10%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	971.44	886.87	782.75	709.26	522.05	519.87
	9.40	8.35	6.22	4.46	4.89	5.20
	980.84	895.23	788.97	713.72	526.94	525.07
	841.83	778.95	695.65	647.39	521.39	456.42
	572.40	516.87	500.90	425.04	299.53	387.80
	0.00	0.00	0.00	—	—	—
	98.58	87.92	80.08	64.15	55.04	51.02
	43.92	23.08	18.54	23.46	21.91	18.88
	35.88	39.92	34.34	31.52	32.13	32.15
	123.33	134.00	126.61	30.79	19.37	24.03
	139.03	116.27	93.32	66.33	5.55	68.66
	0.00	0.00	0.00	—	—	—
	139.03	116.27	93.32	66.33	5.55	68.66
	34.49	28.66	24.94	16.91	1.47	0.62
	104.52	87.61	68.38	49.42	4.08	68.04
	11.30	9.58	8.07	5.84	0.48	8.04
Key metrics
	218.83	179.27	146.20	121.31	59.59	119.69
	22.53%	20.20%	18.70%	17.10%	11.40%	23.00%
	10.76%	9.90%	8.70%	7.00%	0.80%	13.10%
	—	13.50%	13.00%	—	—	—
	12.95%	13.30%	10.40%	35.90%	0.40%	—
	28.81%	28.10%	38.40%	1,111.30%	-94.00%	—
	—	-64.43	-41.67	—	—	—
	—	0.69	1.19	—	—	—
	—	0.45	0.46	—	—	—
	—	319.27	269.36	—	—	—
	—	183.7	174.5	—	—	—
Balance sheet
	—	1,381	1,186	—	—	—
	—	636.57	554.46	—	—	—
	—	45.78	41.39	—	—	—
	—	215.88	203.23	—	—	—
	—	350.95	284.73	—	—	—
	—	20.31	14.64	—	—	—
	—	531.22	530.85	—	—	—
	—	120.39	113.91	—	—	—
	—	352.54	324.36	—	—	—
	—	365.05	310.75	—	—	—
	—	193.41	171.39	—	—	—
	—	171.64	139.36	—	—	—
	—	804.79	673.07	—	—	—
Cash flow
	—	60.68	81.71	—	—	—
	—	-132.33	-123.44	—	—	—
	—	76.03	47.08	—	—	—
	—	125.11	123.38	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +19.32%
Sales CAGR 5Y: —
Profit CAGR 3Y: +177.95%
Profit CAGR 5Y: —
Sales YoY (TTM): +12.95%
Profit YoY (TTM): +28.81%

Consolidated

Sales CAGR 3Y: +19.32%
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +12.96%
Profit YoY (TTM): +38.62%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 68.08%

Quarter	September 2026	June 2026
Promoter %	68.08%	68.08%

Holder	Type	Holding	Previous	Change
RAMESH BABU POTLURI	Promoter	19.38%	19.38%	0.00%
VAMSI KRISHNA POTLURI	Promoter Group	16.90%	16.90%	0.00%
HIMA BINDU POTLURI	Promoter Group	16.03%	16.03%	0.00%
POTLURI INFRA PROJECTS LLP	Promoter Group	9.45%	9.45%	0.00%
TRILOK POTLURI	Promoter Group	5.01%	5.01%	0.00%
ANIRUDDH MUNDRA	Public	1.84%	2.01%	-0.17%
Venkata Subbaraju Penmatsa HUF	Public	1.60%	1.82%	-0.22%
ALPANA MUNDRA	Public	1.50%	—	—
SUDEEPTHI GOPINEEDI	Public	1.41%	1.41%	0.00%
VENKATA PRAVEEN TALLURI	Public	1.41%	1.41%	0.00%
POTLURI LABORATORIES PRIVATE LIMITED	Promoter Group	1.20%	1.20%	0.00%
TVT INFRACON LLP	Promoter Group	0.11%	0.11%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
SMS Pharmaceuticals Ltd	4,930	526.40	42.15	13.80%	+12.96% TTM	+38.62% TTM	+87.06%

Filings & corporate actions

Recent announcements

Press release on Financial Results4 Nov 2026 · Company Update / Press Release / Media Release
Investor Presentation for quarter and half year ended September 30, 20264 Nov 2026 · Company Update / Investor Presentation
Financial results and change in Company Secretary4 Nov 2026 · Company Update / General
Change in Management_Company Secretary4 Nov 2026 · Company Update / Change in Management
Outcome of Board Meeting and Financial Results4 Nov 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Investor's Conference Call2 Nov 2026 · Company Update / Analyst / Investor Meet
Receipt of order from Income Tax Department31 Oct 2026 · Company Update / General
Order Received from the Income Tax Department31 Oct 2026 · Company Update / General
Loan agreement with subsidiary of the Company30 Oct 2026 · Company Update / General
SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve financial results for the ....28 Oct 2026 · Board Meeting / Board Meeting
Certificate under Reg 74(5) of SEBI DP Regulations for quarter ended 30 September 20267 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Scrutinizer report30 Sep 2026 · AGM/EGM / AGM
Proceedings of the Annual General Meeting of the Company29 Sep 2026 · AGM/EGM / AGM
Trading window closure for the quarter and half year ended on 30 September 202624 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Investors Group Meeting10 Sep 2026 · Company Update / Analyst / Investor Meet
Copy of Newspaper Publication5 Sep 2026 · Company Update / Newspaper Publication
Letter to Shareholders4 Sep 2026 · Company Update / General
BRSR for the Financial Year 2025-264 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Notice of 38th Annual General Meeting for the FY 2025-264 Sep 2026 · AGM/EGM / AGM
Annual Report for the Financial Year 2025-264 Sep 2026 · Others / Reg. 34 (1) Annual Report
Credit Rating Intimation2 Sep 2026 · Company Update / Credit Rating
Copy of Newspaper Publication29 Aug 2026 · Company Update / Newspaper Publication
Record date for Dividend has been changed from 16th September, 2026 to 22nd September, 2026.27 Aug 2026 · Corp. Action / Record Date
Change in the date of 38th AGM of the Company from 23rd September, 2026 to 29th September, 2026.27 Aug 2026 · AGM/EGM / AGM
Copy of newspaper publication regarding the 38th Annual General Meeting to be held through VC/ other Audio Visual Means21 Aug 2026 · Company Update / Newspaper Publication
Please find the enclosure6 Aug 2026 · Company Update / General
Copy of Newspaper Publication1 Aug 2026 · Company Update / Newspaper Publication
Investor Presentation1 Aug 2026 · Company Update / Investor Presentation
Press Release on Financial Results1 Aug 2026 · Company Update / Press Release / Media Release
Please find the enclosure31 Jul 2026 · Company Update / General
Fixation of Record date31 Jul 2026 · Corp. Action / Record Date
Re-appointment of Director31 Jul 2026 · Company Update / Change in Management
Please find the enclosure31 Jul 2026 · Result / Financial Results
Please find the enclosure31 Jul 2026 · Board Meeting / Outcome of Board Meeting
The Board Meeting to be held on 01/08/2026 has been revised to 31/07/2026 The Board Meeting to be held on 01/08/2026 has been revised to 31/07/202629 Jul 2026 · Company Update / Board Meeting Rescheduled
SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve Un-audited Financial Results ....25 Jul 2026 · Board Meeting / Board Meeting
Copy of Newspaper Publication for information regarding transfer of shares to IEPF.22 Jul 2026 · Company Update / Newspaper Publication
Please find attached22 Jul 2026 · Company Update / General
Please find the annexure.20 Jul 2026 · Company Update / General
Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 0.4000	22 Sep 2026	22 Sep 2026	—
Final Dividend - Rs. - 0.4000	22 Sep 2025	22 Sep 2025	—
Final Dividend - Rs. - 0.4000	23 Sep 2024	23 Sep 2024	—

Board meetings

4 Nov 2026 Board Meeting - Financial Results
1 Aug 2026 Board Meeting - Financial Results
31 Jul 2026 Board Meeting - Financial Results